Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Aneeb Sharif
SENIOR VICE PRESIDENT (US) & ASSOCIATE DIRECTOR (UK), REPUTATION AND RISK MANAGEMENT, SYNEOS HEALTH
Bringing Value Assessments into the 21st Century: A Multi-Stakeholder Perspective
Khushboo Sharma
CHIEF REGULATORY INNOVATION OFFICER, ACCUMULUS SYNERGY
Combating Misinformation with Authoritative Medical Product Information
Re-Imagining Drug Development and Regulatory Submissions through Cloud-Based Technologies
Placeholder Photo
Ofer Sharon, MBA, MD
CEO, ONCOHOST
OncoHost
Binyamina, Israel
Philip Sharp, PhD
INSTITUTE PROFESSOR, MIT AND INTRAMURAL FACULTY, KOCH INSTITUTE FOR INTEGRATIVE CANCER RESEARCH
Scientific Revolutions: New Therapies Meet New Biology
Jylana Sheats, MPS,PhD
CIVIC SCIENCE FELLOW, THE ASPEN INSTITUTE
New Strategies for Increasing Diversity in Clinical Trials
Washington, United States
Chris Sheldon, PhD
SVP, HEAD OF BUSINESS DEVELOPMENT, GSK
Partnering To Get Ahead of Disease Together
Michael Sherman
VENTURE PARTURE, RA CAPITAL MANAGEMENT
Scaling Approved Patient-Centered Therapies: Resolving the Diagnostic Challenge
Canton, Massachusetts, United States
Kathy Sherman
EXECUTIVE DIRECTOR, STATE & INTERNATIONAL GOVERNMENT AFFAIRS, AMGEN
Business Critical: Building a State/Regional Advocacy Arm
Jim Sherner
EXECUTIVE DIRECTOR AND HEAD OF POLICY, ADVOCACY, AND GOVERNMENT AFFAIRS, SEQIRUS
The Future of the Vaccine Safety Net: Ensuring Equity, Access, Innovation, and the Business of Vaccines
Placeholder Photo
Victor Shifrin, PhD
CEO, IMMUNOCHEM THERAPEUTICS, LLC
ImmunoChem Therapeutics, LLC
Newton, Massachusetts, United States